Clinical Trial

Study of Patient With Frequent Exacerbations in Moscow

Study acronym: CERERA-MOSCOW
Recruiting
View on ClinicalTrials.gov →
Summary
This Study is multicenter, non-interventional, ambispective registry to evaluate the demographic and clinical characteristics, therapeutic approaches and outcomes in COPD outpatients with frequent exacerbations in Moscow
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-12-15; most recent amendment 2026-05-28.
Status change: Not Yet Recruiting → Recruiting 2026-02-03
Trial Details
NCT Number NCT07307781
Lead Sponsor AstraZeneca
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 500 participants
Start Date 2025-11-28
Primary Completion 2027-06-25 (estimated)
Study Completion 2027-06-25 (estimated)
Updated on ClinicalTrials.gov 2026-05-29